Experience

Our commercially savvy lawyers regularly lead strategic transactions and complex disputes for clients in a variety of industries and regions. We’ve included a small selection of matters for your convenience.
Practice
Industry
Region

Hamilton Lane in the acquisition of a significant equity interest in Cosette Pharmaceuticals from Avista and its co-investors through funds managed by Hamilton Lane.

Debevoise & Plimpton LLP is advising Hamilton Lane (NASDAQ: HLNE) in the acquisition of a significant equity interest in Cosette Pharmaceuticals from Avista and its co-investors through funds managed by Hamilton Lane. For more information, please see the company’s press release. Read More>

Resolution Life in the offering of $500 million 8.25% notes due 2031.

Debevoise & Plimpton LLP has advised Resolution Life in its offering of $500 million 8.25% notes due 2031 (the “Notes”). The Notes qualify as Tier 2 regulatory capital under the Bermuda Insurance (Group Supervision) Rules and represent the first listed debt of Resolution Life. Read More>

Valenz Health, a Kelso & Company portfolio company and platform of integrated cost containment and payment integrity solutions, in its acquisition of Healthcare Bluebook, a healthcare cost and quality navigation platform.

Debevoise & Plimpton LLP is advising Valenz Health in its acquisition of Healthcare Bluebook. For more information, please see the company’s press release. Read More>

MetLife Investment Management in a $1.2 billion managed secondary transaction, including a $975 million portfolio disposition of MetLife affiliate assets to its newly raised fund, MetLife Investment Private Equity Partners II.

Debevoise & Plimpton LLP has advised MetLife Investment Management in connection with a $1.2 billion managed secondary transaction, which included a $975 million portfolio disposition of MetLife affiliate private equity and equity co-investment assets to its newly raised fund, MetLife Investment Private Equity Partners II. For more information, please see the company’s press release. Read More>

Safe-Guard Products International, a Stone Point Capital portfolio company, in Hellman & Friedman’s majority investment.

Debevoise & Plimpton LLP is advising Safe-Guard Products International, a Stone Point Capital portfolio company, in a majority investment from Hellman & Friedman. For more information, please see the company’s press release. Read More>

Pactiv Evergreen in the sale of its Pine Bluff, Arkansas, paper mill and Waynesville, North Carolina, extrusion facility, to Suzano.

Debevoise & Plimpton LLP is advising Pactiv Evergreen (NASDAQ: PTVE) in the sale of its Pine Bluff, Arkansas, paper mill and Waynesville, North Carolina, extrusion facility, to Suzano. For more information, please see the company’s press release. Read More>